Orbimed Advisors LLC Immunovant, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$22.61 - $38.9 $8.02 Million - $13.8 Million
-354,575 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$13.87 - $28.44 $2.43 Million - $4.98 Million
175,075 Added 97.53%
354,575 $8.63 Million
Q1 2020

May 15, 2020
BUY
$8.36 - $17.13 $1.5 Million - $3.07 Million
179,500 New
179,500 $2.79 Million

Others Institutions Holding IMVT

# of Institutions
215
Shares Held
66.8M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email